Edison Scientific, a company specializing in artificial intelligence, has formed a partnership with Population Health Partners, an investment firm.
The collaboration aims to harness AI agents to enhance processes in drug discovery and development.
This initiative reflects a growing trend in the biotech industry to integrate advanced technology in scientific research.